Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis.
暂无分享,去创建一个
W. Min | A. Sinusas | W. Sessa | Rong Zhang | Haifeng Zhang | Yun He | Yan Luo | Xianghong Li | Dianhong Luo | W. Dobrucki
[1] P. Carmeliet,et al. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. , 2006, The Journal of clinical investigation.
[2] G. Breier,et al. Continuous Endothelial Cell Activation Increases Angiogenesis: Evidence for the Direct Role of Endothelium Linking Angiogenesis and Inflammation , 2006, Journal of Vascular Research.
[3] P. Vandenabeele,et al. TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] S. Grundmann,et al. Anti-tumor necrosis factor-α therapies attenuate adaptive arteriogenesis in the rabbit , 2005 .
[5] W. Sessa,et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Sessa,et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] Wang Min,et al. AIP1/DAB2IP, a Novel Member of the Ras-GAP Family, Transduces TRAF2-induced ASK1-JNK Activation* , 2004, Journal of Biological Chemistry.
[8] W. Schaper,et al. Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis) , 2004, Circulation research.
[9] R. Beyaert,et al. Function and regulation of tumor necrosis factor receptor type 2. , 2004, Current medicinal chemistry.
[10] W. Min,et al. Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner , 2004, Circulation research.
[11] K. Tsuchida,et al. In vivo transfer of soluble TNF‐alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] W. Min,et al. Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-induced Angiogenic Pathway* , 2003, Journal of Biological Chemistry.
[13] F. Luscinskas,et al. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. , 2003, The American journal of pathology.
[14] A. Hall,et al. Rho GTPases in cell biology , 2002, Nature.
[15] W. Min,et al. Etk/Bmx as a Tumor Necrosis Factor Receptor Type 2-Specific Kinase: Role in Endothelial Cell Migration and Angiogenesis , 2002, Molecular and Cellular Biology.
[16] Y. Qiu,et al. Selective Activation of Small GTPase RhoA by Tyrosine Kinase Etk through Its Pleckstrin Homology Domain* , 2002, The Journal of Biological Chemistry.
[17] L. Moldawer,et al. Direct Evidence for Tumor Necrosis Factor-&agr; Signaling in Arteriogenesis , 2002, Circulation.
[18] Yili Yang,et al. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 , 2002, Nature.
[19] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[20] J. Pober,et al. TNF signaling in vascular endothelial cells. , 2001, Experimental and molecular pathology.
[21] M. Karin,et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. , 1999, Genes & development.
[22] L. Moldawer,et al. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor. , 1999, Journal of vascular surgery.
[23] D. Goeddel,et al. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. , 1999, Science.
[24] J. Isner,et al. Mouse model of angiogenesis. , 1998, The American journal of pathology.
[25] W. Min,et al. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. , 1997, Journal of immunology.
[26] B. Aggarwal,et al. Differential activation of the nuclear factor-kappa B by TNF muteins specific for the p60 and p80 TNF receptors. , 1996, Journal of immunology.
[27] D. Goeddel,et al. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[29] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[30] D. Goeddel,et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.
[31] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[32] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[33] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.
[34] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[35] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[36] L. Tartaglia,et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[38] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[39] H. Tabuchi,et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor , 1990, Cell.
[40] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.
[41] S. Grundmann,et al. Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit. , 2005, American journal of physiology. Heart and circulatory physiology.
[42] R. Murali,et al. The TNF receptor superfamily , 2003, Immunologic research.
[43] Y. Goltsev,et al. Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.
[44] W. Schaper,et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.
[45] W. Fiers,et al. TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. , 1995, Journal of inflammation.
[46] H. Shepard,et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.